Prelude Capital Management, LLC Quotient LTD Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$7.77 - $11.26 $518,740 - $751,740	-66,762 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.91 - $10.25 $32,264 - $41,809	-4,079 Reduced 5.76%	66,762 $624,000
Q1 2019 May 15, 2019	BUY	$6.0 - $11.07 $425,046 - $784,209	70,841 New	70,841 $638,000
Q4 2018 Feb 14, 2019	SELL	$5.81 - $7.89 $60,301 - $81,890	-10,379 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$6.57 - $8.31 $101,835 - $128,805	-15,500 Reduced 59.89%	10,379 $78,000
Q2 2018 Aug 14, 2018	SELL	$3.93 - $8.93 $96,143 - $218,463	-24,464 Reduced 48.59%	25,879 $208,000
Q1 2018 May 15, 2018	BUY	$2.88 - $6.29 $144,987 - $316,657	50,343 New	50,343 $237,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.